NeuroProfile Competitors and Similar CompaniesClear all
NeuroProfile's competitors and similar companies include Neurim Pharmaceuticals, Shionogi, ACADIA Pharmaceuticals and Suven Life Sciences.
 NeuroProfile NeuroProfile is a biotech company supporting the development of therapeutics for central nervous system diseases. |  Neurim Pharmaceuticals Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders. |  Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  ACADIA Pharmaceuticals ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders. |  Suven Life Sciences Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS. | |
Founding Date | Founding Date 2001 | Founding Date 1991 | Founding Date 1878 | Founding Date 1993 | Founding Date 1989 |
Type | Type Private | Type Private | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Tel Aviv-Yafo, IL HQ Zug, CH | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations San Diego, US HQ Princeton, US | Locations Hyderabad, IN HQ Dasaigudem, IN Hyderabad, IN Sangareddy, IN South Brunswick Township, US |
Employees | Employees N/A | Employees 20 | Employees 4,955 | Employees 513 | Employees 141 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 12.3 b | Valuation ($) 2.4 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $1.1b (FY, 2025) | Revenue (est.) ₹71.1m (FY, 2026) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥55.5b (FY, 2026) | Cost of goods $89m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit ¥491.3b (FY, 2026) | Gross profit $982.5m (FY, 2025) | Gross profit ₹210.4m (FY, 2026) |
Net income | Net income N/A | Net income N/A | Net income ¥205.9b (FY, 2026) | Net income $391m (FY, 2025) | Net income (₹2.8b) (FY, 2026) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 4.7m | Total funding raised $ 770.8m | Total funding raised $ 32m |
For sources of this data, please see the company profile
View Company Profiles
Neurim Pharmaceuticals
HQ
Tel Aviv-Yafo, IL
Employees
20
Neurim Pharmaceuticals is a drug discovery and development company that focuses on the central nervous system (CNS) disorders.
View companyShionogi
HQ
Osaka, JP
Employees
4,955
Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases.
View companyACADIA Pharmaceuticals
HQ
San Diego, US
Employees
513
ACADIA Pharmaceuticals (formerly Receptor Technologies) is a biopharmaceutical company developing medicines that address medical needs in related central nervous system (CNS) disorders.
View companySuven Life Sciences
HQ
Hyderabad, IN
Employees
141
Suven Life Sciences is a biopharmaceutical company specialized in NCE-based CRAMS.
View company